These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 38466550)
1. In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds. Ramos MLM; Almeida-Silva F; de Souza Rabello VB; Nahal J; Figueiredo-Carvalho MHG; Bernardes-Engemann AR; Poester VR; Xavier MO; Meyer W; Zancopé-Oliveira RM; Frases S; Almeida-Paes R Braz J Microbiol; 2024 Jun; 55(2):1359-1368. PubMed ID: 38466550 [TBL] [Abstract][Full Text] [Related]
2. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622 [TBL] [Abstract][Full Text] [Related]
3. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug. Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218 [TBL] [Abstract][Full Text] [Related]
5. Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine. Almeida-Paes R; Figueiredo-Carvalho MH; Brito-Santos F; Almeida-Silva F; Oliveira MM; Zancopé-Oliveira RM PLoS One; 2016; 11(3):e0152796. PubMed ID: 27031728 [TBL] [Abstract][Full Text] [Related]
6. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil. Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836 [TBL] [Abstract][Full Text] [Related]
7. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility. Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207 [TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases. Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246 [TBL] [Abstract][Full Text] [Related]
9. Sporotrichosis caused by Sporothrix brasiliensis in Argentina: Case report, molecular identification and in vitro susceptibility pattern to antifungal drugs. Etchecopaz AN; Lanza N; Toscanini MA; Devoto TB; Pola SJ; Daneri GL; Iovannitti CA; Cuestas ML J Mycol Med; 2020 Apr; 30(1):100908. PubMed ID: 31732417 [TBL] [Abstract][Full Text] [Related]
10. Studies in Phylogeny, Development of Rapid IdentificationMethods, Antifungal Susceptibility, and Growth Rates of Clinical Strains of Sporothrix schenckii Complex in Japan. Suzuki R; Yikelamu A; Tanaka R; Igawa K; Yokozeki H; Yaguchi T Med Mycol J; 2016; 57(3):E47-57. PubMed ID: 27581775 [TBL] [Abstract][Full Text] [Related]
11. Anti-Sporothrix activity of ibuprofen combined with antifungal. Borba-Santos LP; Nucci M; Ferreira-Pereira A; Rozental S Braz J Microbiol; 2021 Mar; 52(1):101-106. PubMed ID: 32617835 [TBL] [Abstract][Full Text] [Related]
12. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Córdoba S; Isla G; Szusz W; Vivot W; Hevia A; Davel G; Canteros CE Mycoses; 2018 Jul; 61(7):441-448. PubMed ID: 29500853 [TBL] [Abstract][Full Text] [Related]
13. Milteforan, a promising veterinary commercial product against feline sporotrichosis. García Carnero LC; Pinzan CF; Diehl C; de Castro PA; Pontes L; Rodrigues AM; Dos Reis TF; Goldman GH Microbiol Spectr; 2024 Oct; 12(10):e0047424. PubMed ID: 39194287 [TBL] [Abstract][Full Text] [Related]
14. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542 [TBL] [Abstract][Full Text] [Related]
16. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. Rodrigues AM; de Hoog GS; de Cássia Pires D; Brihante RS; Sidrim JJ; Gadelha MF; Colombo AL; de Camargo ZP BMC Infect Dis; 2014 Apr; 14():219. PubMed ID: 24755107 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil. Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009 [TBL] [Abstract][Full Text] [Related]
18. Antifungal resistance on Sporothrix species: an overview. Waller SB; Dalla Lana DF; Quatrin PM; Ferreira MRA; Fuentefria AM; Mezzari A Braz J Microbiol; 2021 Mar; 52(1):73-80. PubMed ID: 32476087 [TBL] [Abstract][Full Text] [Related]